Adeshwar Meditex Limited reports Rs 4.4212 crore operating cash

Adeshwar Meditex Limited reported Rs 4.4212 crore of net cash from operating activities for the half year ended September 30, 2026. The operating inflow exceeded the Rs 4.3467 crore reduction in short-term borrowings, while cash and bank balances rose to Rs 26.68 lakh from Rs 1.49 lakh at March 31, 2026.

How much operating cash did Adeshwar Meditex generate?

Adeshwar Meditex generated Rs 4.4212 crore of net operating cash in the half year ended September 30, 2026, after paying Rs 22 lakh in taxes. The company reported Rs 4.6412 crore of cash from operations before tax, compared with Rs 5.4879 crore for the year ended March 31, 2026.

Operating profit before working-capital changes was Rs 1.0517 crore in the September 2026 half year, against Rs 2.8133 crore in the year to March 31, 2026. The cash-flow statement uses the indirect method under Accounting Standard 3, beginning with profit before tax and adjusting for items including depreciation, interest and changes in operating assets and liabilities.

The September 2026 figure covers six months, whereas the March 2026 comparison covers a full financial year and is therefore not a like-for-like period comparison. Still, the Rs 4.4212 crore operating inflow was close to the Rs 4.4911 crore financing outflow, leaving net cash and cash equivalents higher by Rs 25.19 lakh.

How did working capital affect Adeshwar Meditex cash flow?

Adeshwar Meditex recorded a Rs 3.5895 crore contribution from working-capital changes in the half year ended September 30, 2026. This was the difference between operating profit before working-capital changes of Rs 1.0517 crore and cash from operations before tax of Rs 4.6412 crore.

The cash-flow statement lists Rs 1.6046 crore from inventories, Rs 1.8892 crore from receivables and Rs 73.23 lakh from payables among the working-capital movements for the September period. It also records Rs 14.14 lakh used in other current assets, Rs 3.61 lakh used in short-term loans and advances, and Rs 37,000 used in other non-current assets.

The balance sheet shows inventories at Rs 18.8961 crore on September 30, 2026, down from Rs 20.5008 crore on March 31, 2026. Trade receivables fell to Rs 18.9397 crore from Rs 20.8189 crore over the same period, alongside half-year revenue from operations of Rs 24.3571 crore.

Did Adeshwar Meditex repay its short-term borrowings?

Adeshwar Meditex reported Rs 4.3467 crore of cash used for changes in short-term borrowings during the half year ended September 30, 2026. Its March 31, 2026 balance sheet showed Rs 4.3467 crore of short-term borrowings, while the September 30 statement does not display a balance for that line.

The short-term borrowing movement was the largest item in financing cash flow, which totalled an outflow of Rs 4.4911 crore for the September half year. The same section shows Rs 16.36 lakh of interest expense, a Rs 2.17 lakh change in long-term borrowings, and Rs 25,000 of changes in other long-term liabilities.

For the year ended March 31, 2026, financing activities used Rs 7.0879 crore, including Rs 5.1686 crore recorded under changes in short-term borrowings. Long-term borrowings increased to Rs 1.6733 crore at September 30, 2026 from Rs 1.6516 crore at March 31, 2026, while share capital remained Rs 14.4314 crore.

How did Adeshwar Meditex liquidity and profits change?

Adeshwar Meditex ended September 30, 2026 with cash and bank balances of Rs 26.68 lakh, compared with Rs 1.49 lakh at March 31, 2026. The closing balance comprised Rs 2.17 lakh of cash on hand and Rs 24.51 lakh in current-account bank balances, matching the cash-flow statement’s Rs 25.19 lakh net increase.

Investing activities generated Rs 32.18 lakh during the September 2026 half year, compared with Rs 9.59 lakh in the year ended March 31, 2026. The half-year statement includes Rs 20.71 lakh related to long-term loans and advances, Rs 4.34 lakh of dividend or bank interest received, and Rs 87,000 spent on tangible or intangible assets.

Revenue from operations was Rs 24.3571 crore for the half year ended September 30, 2026, down from Rs 30.0578 crore in the corresponding half year ended September 30, 2025. Profit before tax declined to Rs 74.69 lakh from Rs 1.0160 crore, while profit after tax declined to Rs 52.09 lakh from Rs 73.10 lakh.

Basic earnings per share were Rs 0.39 in the September 2026 half year, compared with Rs 0.51 a year earlier. Adeshwar Meditex identifies its business as manufacturing and trading medical dressings, bandages, face masks and personal protective equipment kits, but the filing does not provide revenue or cash-flow figures by product category.

Conclusion

The half-year filing shows that Adeshwar Meditex converted operating activity into Rs 4.4212 crore of cash while reporting profit after tax of Rs 52.09 lakh. Inventory and receivable balances both declined from March 31, 2026, and the reported Rs 4.3467 crore short-term borrowing reduction accounted for most of the Rs 4.4911 crore financing outflow.

The filing does not disclose a forward cash-flow target, borrowing plan or scheduled financial event. The next financial statements will clarify whether short-term borrowings remain absent from the balance sheet, whether operating cash remains supported by working-capital movements, and how the Rs 1.6733 crore long-term borrowing balance develops.